Latest News

Motilal Oswal is bullish on Poonawalla Fincorp recommended buy rating on the stock with a target price of Rs 350 in its research report dated December 26, 2022. Read More Top 100 Best Sellers

The order is valued at $18 million (approx Rs 150 crore) and will be spread over three years commencing with the calendar year 2023. Top 100 Best Sellers Read More

The approval granted by the US Food Drug Administration (USFDA) is for the abbreviated new drug application (ANDA), Fulvestrant injection of strength 250 mg/5 mL (50 mg/mL) per single-dose prefilled syringe, the company said in a statement. Read More Top… Read More »Alembic Pharma gets USFDA nod for generic drug to treat breast cancer

The year 2021 was extraordinary for fundraising from the equity and debt routes, while 2022 has seen a slowdown in capital raising owing to elevated volatility provoked by unprecedented inflation globally and the Russia-Ukraine war. Top 100 Best Sellers Read… Read More »Fund mobilisation through equity, debt routes down 20% to Rs 11 lakh crore in 2022

Sharekhan is bullish on Granules India has recommended buy rating on the stock with a target price of Rs 400 in its research report dated December 23, 2022. Read More Top 100 Best Sellers

Fundraising through QIPs declined 72 percent year on year (YoY) — its steepest fall since 2018. IPOs, on the other hand, have been a popular route this year. However, even IPO mop-ups have fallen dramatically, compared with 2021. Read More… Read More »QIPs lose lustre in 2022 as global volatility keeps sentiment weak

With this acquisition, Inox Green has entered the multi brand OEM wind turbine OM business Top 100 Best Sellers Read More

President Bidya Devi Bhandari on Sunday appointed 68-year-old Prachanda as the country#39;s new prime minister as per Article 76 (2) of the Constitution after receiving the CPN-Maoist Centre chairman#39;s claim to the seat, backed by as many as 169 Members… Read More »CPN-Maoist Centre chairman Pushpa Kamal Dahal “Prachanda” set to take oath as Nepal#39;s new PM today

Funds betting on Public sector undertakings, banking financial services and auto stocks were the winners while technology, pharma and healthcare, and ESG funds were the laggards Top 100 Best Sellers Read More

Sharekhan is bullish on Jyothy Labs has recommended buy rating on the stock with a target price of Rs 240 in its research report dated December 23, 2022. Top 100 Best Sellers Read More